文献速递精神分裂症与精神病性障碍儿童青少年精神

全基因组串联重复扩增在22q11.2缺失背景下修饰精神分裂症风险

Genome-wide tandem repeat expansions modify schizophrenia risk in the presence of a 22q11.2 deletion.
PubMed 文献 · Mol Psychiatry · 2026-04-15

该研究对438名携带22q11.2缺失的无关个体进行基因组测序,发现罕见基因内串联重复扩增(TREs)在精神分裂症患者中显著富集,效应量与常见多基因风险相当。TREs偏好位于内含子及剪接邻近区域,可能通过改变甲基化和剪接破坏基因调控,并主要关联前额叶皮层兴奋性和抑制性神经元的差异表达基因。

要点

  • 22q11.2缺失携带者中,罕见基因内TREs显著富集于精神分裂症患者。
  • TREs的效应量与常见多基因风险相当,偏好内含子和剪接邻近区域。
  • 受累基因如DLGAP2和DMPK参与神经发育和突触组织。

核心结论

  • 罕见串联重复扩增是22q11.2缺失携带者发生精神分裂症的重要遗传修饰因素。
  • TREs可能通过改变甲基化和剪接影响基因调控,主要关联前额叶皮层兴奋性和抑制性神经元的差异表达基因。

研究设计与样本

  • 对438名携带22q11.2缺失的无关个体进行基因组测序,比较精神分裂症患者与非患者的罕见基因内TREs富集情况。

主要发现

  • 精神分裂症患者的罕见基因内TREs显著富集,效应量与常见多基因风险相当。
  • TREs相对于其他基因组区域更集中位于内含子和剪接邻近区域。
  • TREs主要关联前额叶皮层兴奋性和抑制性神经元的差异表达基因。
  • 受累基因包括DLGAP2和DMPK,涉及神经发育和突触组织。

临床怎么用

  • 在22q11.2缺失携带者中,可考虑评估罕见基因内TREs作为精神分裂症风险分层指标。
  • TREs涉及的基因调控机制(甲基化、剪接)可为分子机制研究和潜在干预靶点提供线索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Schizophrenia develops in one in every four individuals with a pathogenic 22q11.2 deletion, yet the genetic modifiers influencing the manifestation of schizophrenia in this high-risk group remain incompletely understood. Here, we identify rare tandem repeat expansions (TREs) as significant contributors to schizophrenia risk in this population. Genome sequencing of 438 unrelated individuals with 22q11.2 deletions revealed a marked enrichment of rare genic TREs among those with schizophrenia, with effect sizes comparable to common polygenic risk. These TREs are disproportionately located in intronic and splice-adjacent regions relative to other genomic regions, with evidence suggesting that they disrupt gene regulation through mechanisms including altered methylation and splicing. Cell-type-specific analyses indicate that TREs are primarily associated with differentially expressed genes in excitatory and inhibitory neurons in the prefrontal cortex. Affected genes, including DLGAP2 and DMPK, are involved in neurodevelopment and synaptic organization. These findings extend the role of TREs as genetic modifiers, providing new insights into the molecular mechanisms underlying schizophrenia in this ultra-high-risk population and into the broader biology of idiopathic schizophrenia.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Cheng M, Yin Y, Engchuan W, et al. Genome-wide tandem repeat expansions modify schizophrenia risk in the presence of a 22q11.2 deletion. Mol Psychiatry. 2026. PMID: 41986744. doi:10.1038/s41380-026-03574-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。